Verifying…
Home / Drug A–Z / Nkoyosix Tablets 40 mg

Nkoyosix Tablets 40 mg

NAFDAC Reg. No. A4-9179 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
Nkoyosix Tablets 40 mg
NAFDAC number
A4-9179
Active ingredient
Furosemide
Strength
40 mg
Form
Tablet
Manufacturer
Not listed
Applicant (holder)
Nkoyo Chemists Ltd
Approved
30 Nov 2020
Status
Inactive View on NAFDAC ↗
Registration valid to
29 Nov 2025
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Nkoyosix Tablets 40 mg is on the NAFDAC register with an active registration (A4-9179). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Nkoyosix Tablets 40 mg is used for

From the official U.S. FDA label for furosemide, the active ingredient registered with NAFDAC.

What it is used for

Edema Furosemide tablets are indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide tablets are particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide alone. …

Possible side effects

Adverse reactions are categorized below by organ system and listed by decreasing severity. Gastrointestinal System Reactions 1. hepatic encephalopathy in patients with hepatocellular insufficiency 2. pancreatitis 3. jaundice (intrahepatic cholestatic jaundice) 4. increased liver enzymes 5. anorexia 6. oral and gastric irritation 7. cramping 8. diarrhea 9. constipation 10. nausea 11. vomiting Systemic Hypersensitivity Reactions 1. severe anaphylactic or anaphylactoid reactions (e.g., with shock) 2. systemic vasculitis 3. interstitial nephritis 4. necrotizing angiitis Central Nervous System Reactions 1. tinnitus and hearing loss 2. paresthesias 3. vertigo 4. dizziness 5. headache 6. …

Do not use if

Furosemide tablets are contraindicated in patients with anuria and in patients with a history of hypersensitivity to furosemide.

Warnings

Furosemide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required and dose and dose schedule must be adjusted to the individual patient's needs (see DOSAGE AND ADMINISTRATION ). WARNINGS In patients with hepatic cirrhosis and ascites, furosemide therapy is best initiated in the hospital. In hepatic coma and in states of electrolyte depletion, therapy should not be instituted until the basic condition is improved. …

Pregnancy & breastfeeding

Pregnancy Pregnancy Category C: Furosemide has been shown to cause unexplained maternal deaths and abortions in rabbits at 2, 4 and 8 times the maximal recommended human dose. There are no adequate and well-controlled studies in pregnant women. Furosemide should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. …

Storage

STORAGE Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. Dispense in well-closed, light-resistant containers. Exposure to light might cause a slight discoloration. …

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Nkoyosix Tablets 40 mg

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Nkoyosix Tablets 40 mg

What is in Nkoyosix Tablets 40 mg?

Nkoyosix Tablets 40 mg contains Furosemide (40 mg), as tablet, according to its NAFDAC registration record.

Is Nkoyosix Tablets 40 mg registered with NAFDAC?

Yes. Nkoyosix Tablets 40 mg is listed on the NAFDAC register under registration number A4-9179, and its registration is active as of 5 November 2026.

Has Nkoyosix Tablets 40 mg been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Nkoyosix Tablets 40 mg in our automatically synced alert list.

How can I check that my pack of Nkoyosix Tablets 40 mg is genuine?

Run a free authenticity scan with the NAFDAC number A4-9179, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Nkoyosix Tablets 40 mg used for?

Edema Furosemide tablets are indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide tablets are particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral furosemide may be used in adults for the treatment of hypertens (Summarised from the official U.S. FDA label for furosemide. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Nkoyosix Tablets 40 mg? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.